A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/7/9/945/446917/7-9-945.pdf
Reference23 articles.
1. Incidence course and severity of delayed nausea and vomiting following the administration of high-dose cisplatin;Kris;J Clin Oncol,1985
2. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting;De Mulder;Ann Intern Med,1990
3. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis;Marty;N Engl J Med,1990
4. Incidence of nausea and vomiting with cytotoxic chemotherapy: A prospective randomised trial of anti-emetics;Morran;BMJ,1979
5. Tolerancia, toxicidad y aceptacion del tratamiento quimiotera-pico FAC (5-fluorouracilo, adriamicina y ciciofosfamida) en el cancer de mama, Analsis de 100 pacientes consecutivas;Martin Jimenez;Neoplasia,1988
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prevalence and predictors of long-delayed (> 120 h) chemotherapy-induced nausea and vomiting (CINV)—a systematic review and individual patient data meta-analysis;Supportive Care in Cancer;2023-08
2. Prevenção e tratamento das náuseas e vômitos induzidos pela quimioterapia antineoplásica;Revista Brasileira de Cancerologia;2022-09-23
3. The prevention and treatment of chemotherapy-induced nausea and vomiting in children and adolescents receiving cancer treatment: the current status and possibilities for improvement;Pediatric Hematology/Oncology and Immunopathology;2020-12-22
4. Duration of dexamethasone administration for the prevention of chemotherapy-induced nausea and vomiting – A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2020-08
5. Nausea and Vomiting;The MASCC Textbook of Cancer Supportive Care and Survivorship;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3